These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 38195521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L.
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy.
    Chen ZJ, Wang XD, Wang HS, Chen SD, Zhou LM, Li JL, Shu WY, Zhou JQ, Fang ZY, Zhang Y, Huang M.
    Seizure; 2012 Mar; 21(2):110-7. PubMed ID: 22055352
    [Abstract] [Full Text] [Related]

  • 4. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X, Li X, Zhang T, Zhao L.
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [Abstract] [Full Text] [Related]

  • 5. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
    Wen D, Chen Z, Yang C, Liu H, Li H, Chen J, Dai Q, Zhong G, Qin J, Ni G, Huang M, Zhou L, Wang X.
    J Pharm Biomed Anal; 2018 Feb 05; 149():448-456. PubMed ID: 29169113
    [Abstract] [Full Text] [Related]

  • 6. Comparison of LC-MS/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective.
    Wang Z, Yun Y, Xie X, You C, Miao H, Zhang F, Gao S, Chen W.
    J Clin Lab Anal; 2018 Jan 05; 32(1):. PubMed ID: 28205314
    [Abstract] [Full Text] [Related]

  • 7. Association of valproic acid and 2-propyl-4-pentenoic acid concentrations with adverse reaction in 254 Chinese patients with epilepsy.
    Ma H, Zhu W, Wang C, Pan J, Yang X, Luo J, Wang P.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul 28; 44(7):775-783. PubMed ID: 31413215
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous Determination of Valproic Acid and Its Major Metabolites by UHPLC-MS/MS in Chinese Patients: Application to Therapeutic Drug Monitoring.
    Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L.
    J Chromatogr Sci; 2017 Apr 01; 55(4):436-444. PubMed ID: 27993840
    [Abstract] [Full Text] [Related]

  • 9. Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.
    Wang C, Wang P, Yang LP, Pan J, Yang X, Ma HY.
    Epilepsy Res; 2017 May 01; 132():64-69. PubMed ID: 28315807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact.
    Huang YT, Huang YM, Kung FL, Lin CJ, Jao T, Ho YF.
    CPT Pharmacometrics Syst Pharmacol; 2023 Dec 01; 12(12):1960-1971. PubMed ID: 37735924
    [Abstract] [Full Text] [Related]

  • 14. Potential biomarker of fibroblast growth factor 21 in valproic acid-treated livers.
    Xu X, Guo C, Liang X, Li R, Chen J.
    Biofactors; 2019 Sep 01; 45(5):740-749. PubMed ID: 31120577
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.
    Doré M, San Juan AE, Frenette AJ, Williamson D.
    Pharmacotherapy; 2017 Aug 01; 37(8):900-907. PubMed ID: 28574586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Children versus adults: pharmacokinetic and adverse-effect differences.
    Anderson GD.
    Epilepsia; 2002 Aug 01; 43 Suppl 3():53-9. PubMed ID: 12060006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.